Fabrication and in vitro biocompatibilities of fibrous biocomposites consisting of PCL and M13 bacteriophage-conjugated alginate for bone tissue engineering
Source abstract
Abstract
As the M13 bacteriophage, which has integrin binding and calcium binding sites, provides topological cues from the nanofibrous shape and biochemical cues from the Arg-Gly-Asp (RGD) sequence attached to the surface of fibrous phage, it has been recommended as a bioactive component for use in bone tissue engineering. However, although it has good biological activities, its low mechanical properties and low processing ability represent major issues that must be overcome before its use as a tissue engineering substitute. To overcome these issues, we chemically conjugated the M13 bacteriophage and alginate with a cross-linking agent and it was used as a bioactive component on electrospun poly(ε-caprolactone) (PCL) micro/nanofibres. Assessment of the physical properties and in vitro biocompatibility using osteoblast-like cells indicated that the biocomposite supplemented with the conjugated phage/alginate was mechanically enhanced, and the extent of mineralisation of cells on the composite was significantly higher compared to that on the fibrous composites fabricated using physically mixed M13 phage/alginate and RGD-modified alginate. These results indicate that M13 phage-conjugated alginate may have potential to be used as an excellent bioactive component for bone tissue regeneration.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomechatronic Engineering
College of Biotechnology and Bioengineering
Sungkyunkwan University
Suwon 440-746
Republic of Korea
Department of Genetic Engineering
References (52)
Show source-provided references
1. Kessler · Organogenesis · 2008 · 4 · 2810.4161/org.6116 ↗
2. Ji · Pharm. Res. · 2011 · 28 · 125910.1007/s11095-010-0320-6 ↗
3. Luo · Adv. Healthcare Mater. · 2013 · 2 · 77710.1002/adhm.201200303 ↗
4. Rim · Biomed. Mater. · 2013 · 8 · 01410210.1088/1748-6041/8/1/014102 ↗
5. Yoshimoto · Biomaterials · 2003 · 24 · 207710.1016/S0142-9612(02)00635-X ↗
6. Zhang · Biomacromolecules · 2005 · 6 · 258310.1021/bm050314k ↗
7. Fu · Int. J. Nanomed. · 2014 · 9 · 233510.2147/IJN.S61375 ↗
8. Gautam · Mater. Sci. Eng., C · 2013 · 33 · 122810.1016/j.msec.2012.12.015 ↗
9. Ghasemi-Mobarakeh · Biomaterials · 2008 · 29 · 453210.1016/j.biomaterials.2008.08.007 ↗
10. Kim · J. Mater. Chem. B · 2013 · 1 · 318510.1039/c3tb20485e ↗
11. Lee · J. Mater. Chem. · 2011 · 21 · 630510.1039/c0jm03414b ↗
12. Yeo · Chem. Mater. · 2011 · 24 · 90310.1021/cm201119q ↗
13. Kuo · Biomaterials · 2001 · 22 · 51110.1016/S0142-9612(00)00201-5 ↗
14. Cohen · Tissue Eng. · 2006 · 12 · 132510.1089/ten.2006.12.1325 ↗
15. Adams · Nature · 1998 · 393 · 34910.1038/30700 ↗
16. Nam · Science · 2006 · 312 · 88510.1126/science.1122716 ↗
17. Lee · Nat. Nanotechnol. · 2012 · 7 · 35110.1038/nnano.2012.69 ↗
18. Li · Bioconjugate Chem. · 2010 · 21 · 136910.1021/bc900405q ↗
19. Ghosh · Nat. Nanotechnol. · 2012 · 7 · 67710.1038/nnano.2012.146 ↗
20. Chung · Nature · 2011 · 478 · 36410.1038/nature10513 ↗
21. Wang · Sci. Rep. · 2013 · 3 · 124210.1038/srep01242 ↗
22. Yoo · Langmuir · 2011 · 28 · 216610.1021/la203840n ↗
23. Merzlyak · Bioconjugate Chem. · 2009 · 20 · 230010.1021/bc900303f ↗
24. J. Sambrook and D. W.Russell, Molecular Cloning: A Laboratory Manual, CSH Laboratory Press, Cold Spring Harbor, New York, 2001
25. Kokubo · Biomaterials · 2006 · 27 · 290710.1016/j.biomaterials.2006.01.017 ↗
26. Merzlyak · Nano Lett. · 2009 · 9 · 84610.1021/nl8036728 ↗
27. Wang · Adv. Mater. · 2014 · 26 · 496110.1002/adma.201400154 ↗
28. Li · Analyst · 2010 · 135 · 2110.1039/B911883G ↗
29. Yi · Nano Lett. · 2012 · 12 · 117610.1021/nl2031663 ↗
30. Jin · Biomaterials · 2014 · 35 · 923610.1016/j.biomaterials.2014.07.044 ↗
31. Yoo · Adv. Healthcare Mater. · 201510.1002/adhm.201500179 ↗
32. HunáLee · Chem. Commun. · 2013 · 49 · 175910.1039/c3cc38871a ↗
33. Oh · Nat. Commun. · 2014 · 5 · 304310.1038/ncomms4043 ↗
34. Jeon · J. Mater. Chem. B · 2014 · 2 · 17110.1039/C3TB21230K ↗
35. Atha · J. Biol. Chem. · 1981 · 256 · 1210810.1016/S0021-9258(18)43240-1 ↗
36. Hosek · Phys. Rev. E: Stat., Nonlinear, Soft Matter Phys. · 2004 · 69 · 05190710.1103/PhysRevE.69.051907 ↗
37. Vanderhooft · Macromol. Biosci. · 2009 · 9 · 2010.1002/mabi.200800141 ↗
38. Ghosh · Biomacromolecules · 2005 · 6 · 285710.1021/bm050361c ↗
39. Wilson · Tissue Eng. · 2005 · 11 · 110.1089/ten.2005.11.1 ↗
40. Mitra · Nat. Rev. Mol. Cell Biol. · 2005 · 6 · 5610.1038/nrm1549 ↗
41. Rechendorff · Langmuir · 2006 · 22 · 1088510.1021/la0621923 ↗
42. Scopelliti · PLoS One · 2010 · 5 · e1186210.1371/journal.pone.0011862 ↗
43. Zadpoor · Mater. Sci. Eng., C · 2014 · 35 · 13410.1016/j.msec.2013.10.026 ↗
44. Liu · Langmuir · 2011 · 27 · 908810.1021/la2018105 ↗
45. Kim · Colloids Surf., B · 2015 · 125 · 18110.1016/j.colsurfb.2014.11.033 ↗
46. Su · RSC Adv. · 2014 · 4 · 1483310.1039/C3RA46457A ↗
47. McNamara · Biomaterials · 2012 · 33 · 283510.1016/j.biomaterials.2011.11.047 ↗
48. Kyle · Biomaterials · 2015 · 52 · 8810.1016/j.biomaterials.2015.02.003 ↗
49. Yan · J. Biomed. Mater. Res., Part A · 2013 · 101 · 96310.1002/jbm.a.34398 ↗
50. Chen · Biomaterials · 2006 · 27 · 397310.1016/j.biomaterials.2006.02.043 ↗
51. Discher · Science · 2005 · 310 · 113910.1126/science.1116995 ↗
52. Pelham · Biol. Bull. · 1998 · 34810.2307/1543109 ↗